Efficacy of transfusion of platelet concentrates obtained by manual pooling or by semiautomated pooling of buffy-coats: A retrospective analysis of count increment, corrected count increment and transfusion interval

Vox Sanguinis

Volumn 96, Issue 1, 2009, Pages 29-33

  Cid, J ^a   Ramiro, L ^b   Escoda, L ^a   Llorente, A ^a  

^a HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

^b Blood and Tissue Bank   (Spain)

Author keywords

Blood component preparation method; Corrected count increment; Count increment; Platelet transfusion; Transfusion interval

Indexed keywords

THROMBOCYTE CONCENTRATE;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD COMPONENT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUTOMATION; CELL SEPARATION; CENTRIFUGATION; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; MALE; MIDDLE AGED; PLATELET COUNT; PLATELET TRANSFUSION; PLATELETPHERESIS; RETROSPECTIVE STUDIES; THROMBOCYTOPENIA; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 57449092271     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/j.1423-0410.2008.01120.x     Document Type: Article

References (18)

1. Murphy S : Platelets from pooled buffy coats: an update. Transfusion 2005 45 : 634 639
2. Gulliksson H, Sjodin A, Sandgren P, Vesterinen M, Larsson S, Diedrich B : Automated preparation of platelet concentrates from pooled buffy coats using the Gambro OrbiSac system. Transfus Apher Sci 2003 29 : 11 12
3. Vetlesen A, Mirlashari MR, Ezligini F, Kjeldsen-Kragh J : Evaluation of platelet activation and cytokine release during storage of platelet concentrates processed from buffy coats either manually or by the automated OrbiSac system. Transfusion 2007 47 : 126 132
4. Larsson S, Sandgren P, Sjodin A, Vesterinen M, Gulliksson H : Automated preparation of platelet concentrates from pooled buffy coats: in vitro studies and experiences with the OrbiSac system. Transfusion 2005 45 : 743 751
5. Cid J, Claparols M, Pinacho A, Hernandez JM, Ortiz P, Puig LS, Pla RP : Comparison of blood component preparation methods from whole blood bags based on buffy coat extraction. Transfus Apher Sci 2007 36 : 243 247
6. Mosteller RD : Simplified calculation of body-surface area. N Engl J Med 1987 317 : 1098
7. Yankee RA, Grumet FC, Rogentine GN : Platelet selection by HLA matching. N Engl J Med 1973 288 : 760 767
8. Janetzko K, Kluter H, van Waeg G, Eichler H : Fully automated processing of buffy-coat-derived pooled platelet concentrates. Transfusion 2004 44 : 1052 1058
9. Larrea L, Ortiz de Salazar MI, Roig R, Soler MA : Fully automated processing of buffy coat-derived pooled concentrates. Transfusion 2005 45 : 642 643
10. Klumpp TR, Herman JH, Gaughan JP, Russo RR, Christman RA, Goldberg SL, Ackerman SJ, Bleecker GC, Mangan KF : Clinical consequences of alterations in platelet transfusion dose: a prospective, randomized, double-blind trial. Transfusion 1999 39 : 674 681
11. Norol F, Bierling P, Roudot-Thoraval F, Le Coeur FF, Rieux C, Lavaux A, Kuentz M, Duedari N : Platelet transfusion: a dose-response study. Blood 1998 92 : 1448 1453
12. Cid J, Lozano M : Lower or higher doses for prophylactic platelet transfusions: results of a meta-analysis of randomized controlled trials. Transfusion 2007 47 : 464 470
13. McCullough J, Vesole DH, Benjamin RJ, Slichter SJ, Pineda A, Snyder E, Stadtmauer EA, Lopez-Plaza I, Coutre S, Strauss RG, Goodnough LT, Fridey JL, Raife T, Cable R, Murphy S, Howard F, Davis K, Lin JS, Metzel P, Corash L, Koutsoukos A, Lin L, Buchholz DH, Conlan MG : Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT Trial. Blood 2004 104 : 1534 1541
14. van Rhenen D, Gulliksson H, Cazenave JP, Pamphilon D, Ljungman P, Kluter H, Vermeij H, Kappers-Klunne M, de Greef G, Laforet M, Lioure B, Davis K, Marblie S, Mayaudon V, Flament J, Conlan M, Lin L, Metzel P, Buchholz D, Corash L : Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment: the euroSPRITE trial. Blood 2003 101 : 2426 2433
15. Bishop JF, Matthews JP, McGrath K, Yuen K, Wolf MM, Szer J : Factors influencing 20-hour increments after platelet transfusion. Transfusion 1991 31 : 392 396
16. Ishida A, Handa M, Wakui M, Okamoto S, Kamakura M, Ikeda Y : Clinical factors influencing posttransfusion platelet increment in patients undergoing hematopoietic progenitor cell transplantation - a prospective analysis. Transfusion 1998 38 : 839 847
17. Slichter SJ, Davis K, Enright H, Braine H, Gernsheimer T, Kao KJ, Kickler T, Lee E, McFarland J, McCullough J, Rodey G, Schiffer CA, Woodson R : Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients. Blood 2005 105 : 4106 4114
18. The TRAP Study Group : Leukocyte reduction and UV-B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. N Engl J Med 1997 337 : 1861 1869